SPECIES-SPECIFICITY IN THE CELL-FREE CONVERSION OF PRION PROTEIN TO PROTEASE-RESISTANT FORMS - A MODEL FOR THE SCRAPIE SPECIES BARRIER

被引:319
作者
KOCISKO, DA
PRIOLA, SA
RAYMOND, GJ
CHESEBRO, B
LANSBURY, PT
CAUGHEY, B
机构
[1] MIT,DEPT CHEM,CAMBRIDGE,MA 02139
[2] NIAID,ROCKY MT LABS,PERSISTENT VIRAL DIS LAB,HAMILTON,MT 59840
关键词
D O I
10.1073/pnas.92.9.3923
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Scrapie is a transmissible neurodegenerative disease that appears to result from an accumulation in the brain of an abnormal protease-resistant isoform of prion protein (PrP) called PrPsc. Conversion of the normal, protease-sensitive form of PrP (PrPc) to protease-resistant forms like PrPsc has been demonstrated in a cell-free reaction composed largely-of hamster PrPc and PrPsc, We now report studies of the species specificity of this cell-free reaction using mouse, hamster, and chimeric PrP molecules, Combinations of hamster PrPc with hamster PrPsc and mouse PrPc with mouse PrPsc resulted in the conversion of PrPc to protease-resistant forms, Protease-resistant PrP species were also generated in the nonhomologous reaction of hamster PrPc with mouse PrPsc, but little conversion was observed in the reciprocal reaction, Glycosylation of the PrPc precursors was not required for species specificity in the conversion reaction, The relative conversion efficiencies correlated with the relative transmissibilities of these strains of scrapie between mice and hamsters, Conversion experiments performed with chimeric mouse/hamster PrPc precursors indicated that differences between PrPc and PrPsc at residues 139, 155, and 170 affected the conversion efficiency and the size of the resultant protease-resistant PrP species. We conclude that there is species specificity in the cell-free interactions that lead to the conversion of PrPc to protease-resistant forms, This specificity may be the molecular basis for the barriers to interspecies transmission of scrapie and other transmissible spongiform encephalopathies in vivo.
引用
收藏
页码:3923 / 3927
页数:5
相关论文
共 37 条
  • [1] Diringer H., Gelderblom H., Hilmert H., Ozel M., Edelbluth C., Kimberlin R.H., Nature (London), 306, pp. 476-478, (1983)
  • [2] Prusiner S.B., McKinley M.P., Bowman K.A., Bendheim P.E., Bolton D.C., Groth D.F., Glenner G.G., Cell, 35, pp. 349-358, (1983)
  • [3] Hope J., Morton L.J.D., Farquhar C.F., Multhaup G., Beyreuther K., Kimberlin R.H., EMBO J., 5, pp. 2591-2597, (1986)
  • [4] Oesch B., Westaway D., Walchli M., McKinley M.P., Kent S.B.H., Aebersold R., Barry R.A., Tempst P., Teplow D.B., Hood L.E., Prusiner S.B., Weissmann C., Cell, 40, pp. 735-746, (1985)
  • [5] Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., Prusiner S.B., Proc. Natl. Acad. Sci. USA, 83, pp. 2310-2314, (1986)
  • [6] Rubenstein R., Kascsak R.J., Merz P.A., Papini M.C., Carp R.I., Robakis N.K., Wisniewski H.M., J. Gen. Virol., 67, pp. 671-681, (1986)
  • [7] Borchelt D.R., Scott M., Taraboulos A., Stahl N., Prusiner S.B., J. Cell Biol., 110, pp. 743-752, (1990)
  • [8] Caughey B., Raymond G.J., J. Biol. Chem., 266, pp. 18217-18223, (1991)
  • [9] Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., Prusiner S.B., Biochemistry, 32, pp. 1991-2002, (1993)
  • [10] McKinley M.P., Bolton D.C., Prusiner S.B., Cell, 35, pp. 57-62, (1983)